Teva Pharmaceutical Industries Acquires Ratiopharm

iStock_000006963239Medium1-300x299It has been announced that Teva Pharmaceutical Industries has acquired Germany’s second largest generics producer, Ratiopharm.  

It is hoped the move will ensure Teva secures the top position in the Eurpean generics market. – notably Germany, Spain, Italy and France.

In addition to this, the acquisition of Ratiopharm – who have strong know-how in biocimilars, should thus strengthen Teva’s portfolio of biopharmaceutical and biogeneric products.

Over the years, Teva has been no stranger to acquisitions – it’s last major one being that of Barr Pharmaceutical s, a US-based multinational generic pharmaceutical company. This boosted Teva’s portfolio of generuc pharmaceutical products, as well as women’s health products.


Are you looking for a job in the Pharmaceutical Industry? Click here to search our current pharmaceutical jobs online now.

Posted in: General, News
CK Logo in place of featured image